Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Salvetti

Showing results (181-190 of 231) with videos related to

Pageof 24
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2021
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigationDaniele Belvisi, Marco Canevelli, Viola Baione, et al.
International Journal of Molecular Sciences|October 27, 2022
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot StudySilvia Romano, Carmela Romano, Martina Peconi, et al.
Journal of Neuroimmunology|October 2, 2018
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patientsViviana Annibali, Renato Umeton, Antonia Palermo, et al.
European Journal of Neurology|November 9, 2021
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trialsMatteo Garibaldi, Tommaso Nicoletti, Elisabetta Bucci, et al.
Annals of Neurology|October 22, 2005
Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide studyGiovanni Ristori, Stefania Cannoni, Maria Antonietta Stazi, et al.
Journal of Medical Genetics|March 29, 2011
Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effectsLaura Bergamaschi, Maria Ban, Nadia Barizzone, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2021
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort studyMaria Pia Sormani, Irene Schiavetti, Doriana Landi, et al.
Annals of Neurology|June 18, 2026
From Marginal to Central: Marginal Zone-like B Cells as Critical Targets in Cladribine-Treated Multiple SclerosisMarta Pirronello, Mario Picozza, Gisella Guerrera, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 5, 2018
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosisDoriana Landi, Paolo Ragonese, Luca Prosperini, et al.
Clinical Immunology (Orlando, Fla.)|February 19, 2026
Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatmentClaudia Russo, Clorinda Fusco, Fortunata Carbone, et al.
Pageof 24

Showing results (181-190 of 231) with videos related to

Sort By:
Pageof 24
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2021
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigationDaniele Belvisi, Marco Canevelli, Viola Baione, et al.
International Journal of Molecular Sciences|October 27, 2022
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot StudySilvia Romano, Carmela Romano, Martina Peconi, et al.
Journal of Neuroimmunology|October 2, 2018
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patientsViviana Annibali, Renato Umeton, Antonia Palermo, et al.
European Journal of Neurology|November 9, 2021
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trialsMatteo Garibaldi, Tommaso Nicoletti, Elisabetta Bucci, et al.
Annals of Neurology|October 22, 2005
Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide studyGiovanni Ristori, Stefania Cannoni, Maria Antonietta Stazi, et al.
Journal of Medical Genetics|March 29, 2011
Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effectsLaura Bergamaschi, Maria Ban, Nadia Barizzone, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2021
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort studyMaria Pia Sormani, Irene Schiavetti, Doriana Landi, et al.
Annals of Neurology|June 18, 2026
From Marginal to Central: Marginal Zone-like B Cells as Critical Targets in Cladribine-Treated Multiple SclerosisMarta Pirronello, Mario Picozza, Gisella Guerrera, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 5, 2018
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosisDoriana Landi, Paolo Ragonese, Luca Prosperini, et al.
Clinical Immunology (Orlando, Fla.)|February 19, 2026
Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatmentClaudia Russo, Clorinda Fusco, Fortunata Carbone, et al.
Pageof 24